SCHEMBL8896551

SCHEMBL8896551

CCOC(=O)c1ccc(Sc2cccc3c2C(C)(C)CCC3(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.47
RXRB P28702 2/20 0.47
RXRG P48443 2/20 0.47
RARB P10826 5/20 0.43
RARA P10276 4/20 0.43
RARG P13631 2/20 0.43
GSTP1 P09211 1/20 0.43
GSTM2 P28161 1/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ESR1 P03372 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
ESR2 Q92731 1/20 0.41
CA14 Q9ULX7 1/20 0.41
MAPK1 P28482 2/20 0.41
PTGIR P43119 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8895056 0.82 RXRA (0.64) RXRARXRBRXRGRARBRARA
SCHEMBL8015924 0.82 RXRA (0.71) RXRARXRBRXRGRARBRARA
SCHEMBL8005372 0.81 RXRA (0.56) RXRARXRBRXRGRARBRARA
SCHEMBL8013613 0.81 RXRA (0.53) RXRARXRBRXRGRARBRARA
SCHEMBL8014568 0.79 RXRA (0.67) RXRARXRBRXRGRARBRARA
SCHEMBL8020041 0.78 RXRA (0.53) RXRARXRBRXRGRARBRARA
SCHEMBL28510538 0.74 CA1 (0.66) GSTP1GSTM2CA12CA1CA2
SCHEMBL20544907 0.72 MEN1 (0.59) CA12CA1CA2ESR1CA7
SCHEMBL8896356 0.71 RARB (0.53) RXRARXRBRXRGRARBRARA
SCHEMBL3819796 0.71 RARB (0.60) RXRARXRBRXRGRARBRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672710-A SPECIFIC AGONISTS FOR THE RXR RETINOID RECEPTOR RATHER THAN THE RAR ONE; SIDE EFFECT REDUCTION; SKIN AND NERVOUS SYTEM DISORDERS; ANTICARCINOGENIC AGENTS; VISION DEFECTS ALLERGAN (US) 1997-09-30 US disclosed
WO-1997016422-A1 SULFIDES, SULFOXIDES AND SULFONES DISUBSTITUTED WITH A TETRAHYDRONAPHTHALENYL, CHROMANYL, THIOCHROMANYL OR TETRAHYDROQUINOLINYL AND SUBSTITUTED PHENYL OR HETEROARYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN (US) 1997-05-09 WO disclosed